Pfizer Vaccine Clears FDA Hurdle as the First Doses are Administered in the UK


Jordan Bivins

In early November, it was announced that the company Pfizer had gone into phase 3 of the FDA approval along with BioNTech. Now in December, a month later, Pfizer is in the lead for the Covid vaccine in the United States after it cleared a major hurdle. The Food and Drug Administration has confirmed the safety and efficacy of Pfizer’s coronavirus vaccine candidate. This is an important step for the vaccine process because it gets us one step closer to having it administered to healthcare workers and high risk patients. Pfizer was aiming to start administering their vaccine by December and they are just not in the United States.

In the United Kingdom, 90-year-old Margaret Keenan was the first to have the dose of the Pfizer Covid-19 vaccine. The health secretary, Matt Hancock, has dubbed the day as “V-day.” He said, “Today marks the start of the fightback against our common enemy, the coronavirus.” England’s Prime Minister, Boris Johnson, also made appearances at the London hospital to see those getting the first doses.

Back in the United States, Pfizer has told the Trump administration it cannot provide substantial additional doses of its coronavirus vaccine until late June or July. Since the announcement of their vaccine other countries have started buying up more of its supply. According to the Washington Post, more than 60 percent of American citizens have said they are willing to take the vaccine when it is accessible. Hamilton freshman Kylie Henmi says, “Yes, I would get the vaccine if it was available to me. I think that if it helps us get back to normal life, I support it.” When it comes down to it, the Covid-19 vaccine will be a major breakthrough in medicine and science that will be a major part of society for years to come.